Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002433
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
The Effects of r-metHuIFN-Gamma on the Lungs of Patients With AIDS
Sponsor:
Amgen
Organization:
NIH AIDS Clinical Trials Information Service
Study Overview
Official Title:
Activation of Alveolar Macrophages by Aerosolized r-metHuIFN-Gamma IFN-Gamma in Patients With AIDS
Status:
COMPLETED
Status Verified Date:
1999-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine safety and tolerance of administering aerosolized recombinant interferon gamma IFN-gamma for 4 weeks in patients with AIDS To examine activation of alveolar macrophages by aerosolized IFN-gamma administration To determine if subcutaneous SC injection of IFN-gamma can activate alveolar macrophages in AIDS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IFNG-8901 | None | None | None |